2025 Partners
Expertise Partner
genOway is a biotechnology company with over 20 years of expertise in the development of physiologically relevant translational preclinical models. The company has developed a catalog of humanized, “off-the-shelf” cell and mouse models for immuno-oncology to accelerate research into the pathophysiology of cancer and enable the assessment of new therapeutic agents. Founded in 1999, genOway currently operates in more than 28 countries with 380 academic institutions and 170 life science companies, including 17 of the top 20 pharmaceutical companies.
Expertise Partner
At Seromyx Systems we harness the power of cutting-edge technology, including highthroughput cell and bead-based assays coupled with machine learning computational analysis, to measure and understand the intricate functions of antibodies in the immune system.
Our platform, developed by leading experts from the Ragon Institute with Harvard, MIT and Massachusetts General Hospital, empowers pharmaceutical and biotechnology companies to design future monoclonal and immunotherapies with unmatched precision. By deciphering the complex interactions between antibodies and innate immune cells, we identify the key functions driving efficacy in immune responses. Through our comprehensive analysis, we help our clients unlock critical insights, determining the most effective combinations of antibody functions to combat pathogens, infected cells, or tumor cells. Our mission is to revolutionize the field of serology and drive the development of tailored monoclonal and immunotherapies that save lives and improve global health.